Literature DB >> 14672250

Attributes of long-term heavy cannabis users: a case-control study.

A J Gruber1, H G Pope, J I Hudson, D Yurgelun-Todd.   

Abstract

BACKGROUND: Although cannabis is the most widely used illicit drug in the United States, few recent American studies have examined the attributes of long-term heavy cannabis users.
METHOD: Using a case-control design, we obtained psychological and demographic measures on 108 individuals, age 30-55, who had smoked cannabis a mean of 18000 times and a minimum of 5000 times in their lives. We compared these heavy users to 72 age-matched control subjects who had smoked at least once, but no more than 50 times in their lives.
RESULTS: We found no significant differences between the two groups on reported levels of income and education in their families of origin. However, the heavy users themselves reported significantly lower educational attainment (P < 0.001) and income (P = 0.003) than the controls, even after adjustment for a large number of potentially confounding variables. When asked to rate the subjective effects of cannabis on their cognition, memory, career, social life, physical health and mental health, large majorities of heavy users (66-90%) reported a 'negative effect'. On several measures of quality of life, heavy users also reported significantly lower levels of satisfaction than controls.
CONCLUSION: Both objective and self-report measures suggest numerous negative features associated with long-term heavy cannabis use. Thus, it seems important to understand why heavy users continue to smoke regularly for years, despite acknowledging these negative effects. Such an understanding may guide the development of strategies to treat cannabis dependence.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14672250     DOI: 10.1017/s0033291703008560

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  25 in total

1.  Marijuana Use and Driving Under the Influence among Young Adults: A Socioecological Perspective on Risk Factors.

Authors:  Carla J Berg; Carmen N Daniel; Milkie Vu; Jingjing Li; Kathleen Martin; Lana Le
Journal:  Subst Use Misuse       Date:  2017-08-04       Impact factor: 2.164

2.  The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study.

Authors:  Jung Yeon Lee; Judith S Brook; Mario De La Rosa; Youngjin Kim; David W Brook
Journal:  Am J Drug Alcohol Abuse       Date:  2017-03-01       Impact factor: 3.829

Review 3.  Psychosocial sequelae of cannabis use and implications for policy: findings from the Christchurch Health and Development Study.

Authors:  David M Fergusson; Joseph M Boden; L John Horwood
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-26       Impact factor: 4.328

4.  Reductions in cannabis use are associated with improvements in anxiety, depression, and sleep quality, but not quality of life.

Authors:  Yih-Ing Hser; Larissa J Mooney; David Huang; Yuhui Zhu; Rachel L Tomko; Erin McClure; Chih-Ping Chou; Kevin M Gray
Journal:  J Subst Abuse Treat       Date:  2017-07-29

5.  Identifying risk factors for marijuana use among veterans affairs patients.

Authors:  Marina Goldman; Jesse J Suh; Kevin G Lynch; Regina Szucs; Jennifer Ross; Hu Xie; Charles P O'Brien; David W Oslin
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

6.  Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency department.

Authors:  Edward Bernstein; Erika Edwards; David Dorfman; Tim Heeren; Caleb Bliss; Judith Bernstein
Journal:  Acad Emerg Med       Date:  2009-11       Impact factor: 3.451

7.  A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence.

Authors:  Kenneth M Carpenter; David McDowell; Daniel J Brooks; Wendy Y Cheng; Frances R Levin
Journal:  Am J Addict       Date:  2009 Jan-Feb

Review 8.  Marijuana neurobiology and treatment.

Authors:  Ahmed Elkashef; Frank Vocci; Marilyn Huestis; Margaret Haney; Alan Budney; Amanda Gruber; Nady el-Guebaly
Journal:  Subst Abus       Date:  2008       Impact factor: 3.716

9.  Substance Use Disorders and Neurologic Illness.

Authors:  Robert D. Davies; Christian Thurstone; Kelly Woyewodzic
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

Review 10.  Marijuana dependence and its treatment.

Authors:  Alan J Budney; Roger Roffman; Robert S Stephens; Denise Walker
Journal:  Addict Sci Clin Pract       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.